Sponsor | Study | Subjects (n) | Study site | Gender (male/female) | Age (mean (SD)) | CSF sampling volume/frequency |
---|---|---|---|---|---|---|
AbbVie | A1 | 6 | CCT | 6/10 | 38.2 (9) | 8 ml approximately every 2 hours for 24 hours |
A2 | 22 | CCT | 17/5 | 68.5 (7.2) | 8 ml approximately every 4 hours for 24 hours | |
A3 | 8 | CCT | 8/0 | 35.3 (8.1) | 8 ml approximately every 1 hour for 24 hours; participants repeated study | |
BMS | B1 | 10 | CCT | 10/0 | 31.6 (6.5) | 7 ml every hour for 48 hours |
Lilly | L6 | 6 | LCRU | 60.8 (8.4) | 0.1 ml every 1 minute | |
L7 | 7 | WU | 7/0 | 34 (7) | 6 ml every hour for 36 hours | |
L8 | 10 | PAREXEL | 34.6 (8) | Volume not obtained; every 1 hour for 10 hours; every 2 hours for 26 hours | ||
L5-B | 2 | LCRU | 52.7 (4) | Volume not obtained; every 1 hour for 10 hours | ||
Merck | M1 | 6 | VU | 3/3 | 37.3 (4.6) | 0.5 ml every 5 minutes |
M2 | 3 | CCT | 3/0 | 26 (7) | 6 ml every 1 hour for 8 hours; every 2 hours for 4 hours; after the last 4 hours | |
M3 | 6 | CCT | 4/2 | 54.3 (7.9) | 4.5 ml every 1 hour for 16 hours; every 2 hours for 10 hours | |
M4 | 9 | CCT | 6/2a | 52 (7.8)a | 8 ml every 1 hour for 14 hours; every 2 hours for 12 hours | |
M5 | 6 | CCT | 6/0 | 38.3 (6) | 6 ml every 1 hour for 14 hours; every 2 hours for 12 hours | |
M6 | 4 | SGS | 3/1 | 56.5 (10) | Same as M5 | |
M7 | 4 | SGS | 2/2 | 46.5 (10) | Same as M5 | |
RUMC | R1 | 12 | RUMC | 70.3 (7.5) | 6 ml every 1 hour for 36 hours | |
WU | W1 | 57 | WU | 29/28 | 60.7 (19) | 6 ml every 1 hour for 36 hours |
Total | 178 |